Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): Management with L-ornithine-L-aspartate and stent reduction

被引：6
|
作者：
Stadlbauer, Vanessa
Tauss, Josef
Portugaller, Horst R.
Stiegler, Philipp
Iberer, Florian
Stauber, Rudolf E.
机构：
[1] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria
[2] Med Univ Graz, Dept Radiol, Div Intervent Radiol, Graz, Austria
[3] Med Univ Graz, Dept Surg, Div Transplantat Surg, Graz, Austria
来源：
METABOLIC BRAIN DISEASE | 2007年 / 22卷 / 01期
关键词：
hepatic encephalopathy; venous ammonia levels; transjugular intrahepatic portosystemic shunt; L-ornithine-L-aspartate; stent reduction;
D O I：
10.1007/s11011-006-9032-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hepatic encephalopathy (HE) is a common problem after insertion of a transjugular intrahepatic portosystemic shunt (TIPS), which may be difficult to manage. We present a case of severe post-TIPS HE unresponsive to high doses of L-ornithine-L-aspartate (LOLA) despite reduction of venous ammonia levels in a dose-dependent fashion. Ultimately, high-grade HE was successfully treated by a reduction stent and the patient subsequently underwent successful liver transplantation.
引用
收藏
页码：45 / 50
页数：6
相关论文
共 50 条
  • [21] Reversal of hemolytic anemia and hepatic encephalopathy by transjugular intrahepatic portosystemic shunt occlusion
    Sindhu A. Abraham
    Current Treatment Options in Gastroenterology, 2000, 3 (2) : 105 - 109
  • [22] Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes
    Berenguer, M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2023, 86 (02) : 318 - 322
  • [23] Symptomatic hepatic hydrothorax successfully treated with transjugular intrahepatic portosystemic shunt (TIPS)-role of titration of portosystemic gradient reduction to avoid postTIPS encephalopathy
    Krishnamoorthy, T. L.
    Taneja, M.
    Chang, P. E.
    CLINICAL CASE REPORTS, 2014, 2 (03): : 93 - 97
  • [24] l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials
    Bai, Ming
    Yang, Zhiping
    Qi, Xingshun
    Fan, Daiming
    Han, Guohong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (05) : 783 - 792
  • [25] Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE
    Gerald Kircheis
    Metabolic Brain Disease, 2016, 31 : 1365 - 1367
  • [26] Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE
    Kircheis, Gerald
    METABOLIC BRAIN DISEASE, 2016, 31 (06) : 1365 - 1367
  • [27] Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment - Results of a pilot study
    Delcker, A
    Turowski, B
    Mihm, U
    Raab, P
    Rusch, O
    Pilatus, U
    Zeuzem, S
    Zanella, FE
    METABOLIC BRAIN DISEASE, 2002, 17 (02) : 103 - 111
  • [28] Application of fecal microbial transplantation in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
    Li, Jun
    Wang, Dan
    Sun, Jingping
    MEDICINE, 2022, 101 (03)
  • [29] Proton MR Spectroscopy of Neurometabolites in Hepatic Encephalopathy During L-Ornithine-L-Aspartate Treatment–Results of a Pilot Study
    A. Delcker
    B. Turowski
    U. Mihm
    P. Raab
    O. Rusch
    U. Pilatus
    S. Zeuzem
    F.E. Zanella
    Metabolic Brain Disease, 2002, 17 : 103 - 111
  • [30] Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt
    Yang, Yang
    Liang, Xueqing
    Yang, Shirui
    He, Xiaofeng
    Huang, Mingsheng
    Shi, Wenfeng
    Luo, Junyang
    Duan, Chongyang
    Feng, Xinghui
    Fu, Sirui
    Lu, Ligong
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 154
12345